Pharma Reviews: Sun Pharma CHC enters anti-fungal powder OTC category with ABZORB

Mumbai, Apr 30 (UNI) Sun Pharma Consumer Healthcare (CHC), a division of Sun Pharmaceutical Industries Ltd, "Sun Pharma" including its subsidiaries and/or associate companies) announced its entry into ... The brand will be co-promoted across prescription & OTC channels in India to drive growth.
Read more: Sun Pharma CHC enters anti-fungal powder OTC category with ABZORB

Pharma Jobs: Medical Coding Jobs – 2018 Passed Out Botany/Biology/Zoology/Biochemistry/BPT/Pharmacy/BHMS Grad

Company: Achievers Spot
Qualification: BDS, B.E/B.Tech, BAMS, BHMS, B.Pharm, B.Sc, M.E/M.Tech/MS, M.Pharm, Mphil, M.Sc
Experience: 0 to 1
location: Chennai, Kovilpatti
Ref: 22172390
Summary: Medical Coding is the process of conversion of text information related to....
Read more: Medical Coding Jobs – 2018 Passed Out Botany/Biology/Zoology/Biochemistry/BPT/Pharmacy/BHMS Grad

Pharma Jobs: "Sr.Analyst" Analysts

Company: Merit Matters Academy And HR Services Private Limited
Experience: 2 to 6
location: Chennai
Ref: 22174124
Summary: We are looking for our premier client for the Post of Sr.Analyst & Analyst, located in Chennai for Pharma - QC Chemist

Read more: "Sr.Analyst" Analysts

Pharma Reviews: India-China bilateral trade: Deflating the five most common myths

About 92% of India's imports from China belong to four categories: electronic, engineering, chemicals and pharmaceuticals. India's electronics, power and pharmaceuticals sectors critically rely on China. For example, 90% of active pharmaceutical ingredients (APIs) used by the Indian pharma industry ...
Read more: India-China bilateral trade: Deflating the five most common myths

Pharma Reviews: Medical tourism can be the next big export earner

If India Inc can innovate just like Nasscom did in the 1990s, India's health services sector can grab a portion of the American market by offering world class medical tourism services to American patients. Even a 5 per cent slice can result in a $175 billion export industry, much larger than our IT services ...
Read more: Medical tourism can be the next big export earner

Pharma Jobs: Executive Microbiologist

Company: Solis Invicti Consultancy Private limited
Qualification: M.Sc
Experience: 1 to 5
location: Mumbai
Ref: 22154544
Summary: M.Sc (Biotech) or M.Sc (Microbiology) candidates should apply for this position. The candidate should have also audit experience (FSSAI & ISO FSMS – HACCP) Basic knowledge of MS Office....
Read more: Executive Microbiologist

Pharma Reviews: Rampant evergreening in Indian pharma industry

India has been at the forefront of developing an alternative model of patent law which many developing countries have since emulated. A key highlight in the Indian law is Section 3(d) of The Patents Act, 1970, which was introduced in 2005 as a yardstick to distinguish real innovation from trivial tweaks.
Read more: Rampant evergreening in Indian pharma industry

Pharma Reviews: Focus on risk assessment and safety at 1st edition of analytica Anacon India in Mumbai

There is an increasing focus and adoption of risk based approach and quality metrics in multi product manufacturing by Indian pharma companies to align with global compliance levels. In order to arrive at risk based assessments the pharma companies need to adopt a mitigation plant to identify, ...
Read more: Focus on risk assessment and safety at 1st edition of analytica Anacon India in Mumbai

Pharma Reviews: INSA releases a new book reflecting India's journey in Science and Technology post-independence

The second chapter “Information Technology: how a revolution was seeded”, describes the journey of information technology industry in India starting from the development of the first analogue electronic computer in 1953. The beginning and subsequent events in the Indian pharma industry has been ...
Read more: INSA releases a new book reflecting India's journey in Science and Technology post-independence

Pharma Reviews: Indian analytical instrument industry to reach 2.4B EUR by 2020

The growth in Life Sciences, Pharmaceutical Research, Biotechnology, Chemical, Oil & Gas, Food & Beverage industry is fueling the consumption of analytical instrument in India. Indian analytical instrument industry is expected to reach 2.4 billion EUR by 2020 having CAGR of 17% which currently ...
Read more: Indian analytical instrument industry to reach 2.4B EUR by 2020

Pharma Reviews: 4 years on, code to punish pharma firms for bribing doctors still in works

The Uniform Code of Pharmaceutical Marketing Practices (UCPMP) prepared by the pharmaceuticals department (DoP) to control unethical marketing ... Even the Indian Pharmaceutical Alliance, which represents the top 20 Indian pharmaceutical companies accounting for 46% of domestic sales of ...
Read more: 4 years on, code to punish pharma firms for bribing doctors still in works

US FDA News: Lamictal (lamotrigine): Drug Safety Communication - Serious Immune System Reaction

The FDA is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system. This can cause severe inflammation throughout the body and lead to hospitalization and death, especially if the reaction is not diagnosed and treated quickly. As a result, we are requiring a new warning about this risk be added to the prescribing information in the lamotrigine drug labels. The immune system reaction, called hemophagocytic lymphohistiocytosis (HLH), causes an uncontrolled response by the immune system. HLH typically presents as a persistent fever, usually greater than 101°F, and it can lead to severe problems with blood cells and organs throughout the body such as the liver, kidneys, and lungs.
Read more: Lamictal (lamotrigine): Drug Safety Communication - Serious Immune System Reaction

Pharma Reviews: Law to punish pharma firms that bribed doctors languishing since 2015

Even the Indian Pharmaceutical Alliance, which represents the top 20 Indian pharmaceutical companies accounting for 46% of domestic sales of medicines and 60% of exports, has supported the promulgation of mandatory regulation of unethical practices in the marketing of drugs. In November last ...
Read more: Law to punish pharma firms that bribed doctors languishing since 2015

US FDA News: Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) Devices: Letter to Health Care Providers - Risk of Tissue Overheating Due to Inaccurate Magnetic Resonance Thermometry

FDA is currently evaluating data which suggests that potentially inaccurate MR thermometry information can be displayed during treatment. Posted 04/25/2018
Read more: Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) Devices: Letter to Health Care Providers - Risk of Tissue Overheating Due to Inaccurate Magnetic Resonance Thermometry

US FDA News: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Committee on Appropriations on FDA’s Fiscal Year 2019 budget

FDA Commissioner Scott Gottlieb, M.D. remarks to a U.S. Senate Subcommittee on Appropriations on the FDA’s Fiscal Year 2019 budget
Read more: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Committee on Appropriations on FDA’s Fiscal Year 2019 budget

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new enforcement actions and a Youth Tobacco Prevention Plan to stop youth use of, and access to, JUUL and other e-cigarettes

FDA announces several new enforcement actions and a Youth Tobacco Prevention Plan to stop youth use of, and access to, JUUL and other e-cigarettes.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new enforcement actions and a Youth Tobacco Prevention Plan to stop youth use of, and access to, JUUL and other e-cigarettes

Pharma Reviews: Medical bodies slam PM Modi for his pharma-doctor nexus remark

Indian Medical Association (IMA) and Association of Medical Consultants (AMC) have expressed their anguish over his remarks on the alleged nexus between doctors and pharma companies. The All India Institutes of Medical Sciences' (AIIMS) resident doctors association rued that the PM Modi used ...
Read more: Medical bodies slam PM Modi for his pharma-doctor nexus remark

Pharma Reviews: Pharmexcil to host IPHEX 2018; an international exhibition on pharma and healthcare

New Delhi, Apr 24 (KNN) Pharmaceuticals Export Promotion Council of India (Pharmexcil) set up by Ministry of Commerce and Industry, Govt. of India is going to organize an International Exhibition on Pharma and Healthcare IPHEX 2018 from 8 to 10 May, 2018. The event will offer the industry majors ...
Read more: Pharmexcil to host IPHEX 2018; an international exhibition on pharma and healthcare

Pharma Reviews: Doctors miffed with PM Modi's remarks on them in London

This being so why does the government allow huge profit margin in the Pharmaceutical industry?” Dr Tandon asked. “Why a pharmaceutical company allowed pricing the same drug categorised under different names with different profit margins?” he said, adding that the Indian doctors in no way control ...
Read more: Doctors miffed with PM Modi's remarks on them in London

Pharma Reviews: Doctors miffed with PM Modi's remarks on them in London

The Indian Medical Association (IMA) and Mumbai Association of Medical Consultants (AMC) has expressed disappointment over Prime Minister Narendra Modi's statement in London where he had highlighted alleged nexus between doctors and pharmaceutical firms and said that doctors attend ...
Read more: Doctors miffed with PM Modi's remarks on them in London

Pharma Reviews: Doctors miffed with PM Modi's remarks on them in London

NEW DELHI/MUMBAI/ LUCKNOW: The Indian Medical Association (IMA) and Mumbai Association of Medical Consultant (AMC) has expressed disappointment over Prime Minister Narendra Modi's statement in London where he had highlighted alleged nexus between doctors and pharmaceutical firms ...
Read more: Doctors miffed with PM Modi's remarks on them in London

Pharma Reviews: Rajasthan Villagers Treated as Lab Rats by Foreign Pharma Company, 21 Hospitalised

A victim told News18 that the company had paid Rs 500 per person in exchange for participating in the illegal drug trial. ... According to a report by the Confederation of Indian Industry, companies save up to 60 percent by undertaking the different phases of testing a new drug in India as compared to ...
Read more: Rajasthan Villagers Treated as Lab Rats by Foreign Pharma Company, 21 Hospitalised

Pharma Reviews: India to push for local manufacturing of APIs, reduce dependence on China

New Delhi: In a bid to reduce India's dependence on China for active pharmaceutical ingredients (APIs), the chemicals and fertilizers ministry has joined hands with other ministries to draw up a road map for increasing their production in the country. Bulk drugs or APIs are the active raw materials used in ...
Read more: India to push for local manufacturing of APIs, reduce dependence on China

US FDA News: FDA authorizes new use of test, first to identify the emerging pathogen Candida auris

FDA authorized the first test to identify the emerging pathogen Candida auris, which can cause serious infections in hospitalized patients.
Read more: FDA authorizes new use of test, first to identify the emerging pathogen Candida auris

US FDA News: FDA takes new steps to advance the development of innovative products for treating opioid use disorder

FDA announces new steps to encourage and support the development of treatment options for people with opioid use disorder
Read more: FDA takes new steps to advance the development of innovative products for treating opioid use disorder

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder

FDA announces new steps to encourage more widespread innovation and development of new treatments for opioid use disorder
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder

US FDA News: Federal judge enters consent decree against Cantrell Drug Company

Cantrell Drug Company prohibited from manufacturing and distributing sterile drug products in violation of the law
Read more: Federal judge enters consent decree against Cantrell Drug Company

US FDA News: NxtGen Botanicals Maeng Da Kratom by NGB Corp.: Recall - Possible Salmonella Contamination

NGB Corp. of West Jordan, Utah is voluntarily recalling NxtGen Botanicals Maeng Da Kratom labeled bottles of encapsulated product because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can ressult in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis, and arthritis.
Read more: NxtGen Botanicals Maeng Da Kratom by NGB Corp.: Recall - Possible Salmonella Contamination

US FDA News: Certain Kratom-Containing Powder Products by Viable Solutions: Recall -Possible Salmonella Contamination

Viable Solutions of Nampa, ID has initiated a recall of certain Kratom-containing powder products, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.
Read more: Certain Kratom-Containing Powder Products by Viable Solutions: Recall -Possible Salmonella Contamination

Pharma Reviews: Indian Pharma Inc shifts to high gear in filing patents

Indian pharma is thinking beyond generics and is investing considerably in developing new drugs and filing patents. This change is attributed to the post 2014 drug patent guidelines and facilitation by the Indian government for promotion of innovation, manufacturing and developing India as drug hub, ...
Read more: Indian Pharma Inc shifts to high gear in filing patents

Pharma Reviews: Bengaluru Employees Highest-Paid In India – Rs 10.8 Lakh Is The Average Salary!

After analysing various industries, and sectors, the study found that healthcare and pharma industry pays the maximum salary: Rs 9.6 lakh per annum is the average salary of a professional in health care. Tax experts come at #2, with an average salary ...
Read more: Bengaluru Employees Highest-Paid In India – Rs 10.8 Lakh Is The Average Salary!

Pharma Reviews: Pharma funds may not outperform diversified equity funds any time soon: Sonam Udasi of Tata MF

Many stock market pundits were expecting pharma funds to stage a come back in 2018. However, despite the attractive valuations, pharma funds disappointed investors with negative returns last year. ET.com Mutual Funds spoke to Sonam Udasi, fund manager, Tata India Pharma & HealthCare Fund ...
Read more: Pharma funds may not outperform diversified equity funds any time soon: Sonam Udasi of Tata MF

US FDA News: 24-Hour Multi-Patient Use Endoscope Connectors: Letter to HealthCare Providers and Healthcare Facilities - Risk of Cross-Contamination

the recommended instructions and device design for the ERBEFLO port connector do not adequately mitigate the risks of cross-contamination for endoscopy patients. This is because the connector, tubing, and/or water bottle can become contaminated with blood, stool, or other fluids from previous patients that travel back through the endoscope channels into the connector and tubing. Endoscope connectors that are labeled for use with multiple patients over the course of 24 hours without reprocessing are known as 24-hour multi-patient use endoscope connectors. To date, the FDA has not received acceptable testing to demonstrate the safe use of these products, and recommends against their useTo mitigate the risk of cross-contamination and possible infection between patients, the FDA recommends the use of connectors with features that prevent patient fluids from flowing backwards into the endoscope (backflow prevention features). These connectors may be either single-use connectors that are discarded after each patient, or reusable connectors that are reprocessed according to their instructions for use prior to each patient.
Read more: 24-Hour Multi-Patient Use Endoscope Connectors: Letter to HealthCare Providers and Healthcare Facilities - Risk of Cross-Contamination

US FDA News: Rhino 69 Extreme 50000 by AMA Wholesale: Recall - Presence of Tadalafil

Consumers with diabetes, hypertension, high cholesterol or heart disease often take nitrates; concomitant use of nitrates and PDE5 inhibitors can lead to fatal cardiovascular collapse. Posted 04/18/2018
Read more: Rhino 69 Extreme 50000 by AMA Wholesale: Recall - Presence of Tadalafil

US FDA News: Euphoric Capsules by Epic Products: Recall - Undeclared Sildenafil and Tadalafil

Consumers with diabetes, hypertension, high cholesterol or heart disease often take nitrates; concomitant use of nitrates and PDE-5 inhibitors can lead to fatal cardiovascular collapse. Posted 04/18/2018
Read more: Euphoric Capsules by Epic Products: Recall - Undeclared Sildenafil and Tadalafil

Pharma Reviews: Amid job constraints, here are some of the highest-paying professions in India

While there are several options which help in professional growth, some of them do not pay well enough for an individual to prosper financially, which is a need in today's time. The IT industry has always historically boasted of giving away the best packages but it has now been replaced by the pharma ...
Read more: Amid job constraints, here are some of the highest-paying professions in India

Pharma Reviews: Pharma formulators to invest in growing OTC market: Report

Indian pharmaceutical formulators are expected to continue to make investments in consumer healthcare, wellness products and traditional OTC product categories to grow domestic non-prescription business through organic and inorganic routes, a report said. These investments would be driven by the ...
Read more: Pharma formulators to invest in growing OTC market: Report

US FDA News: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before U.S. House Committee on Appropriations on FDA’s Fiscal Year 2019 budget

FDA Commissioner Scott Gottlieb, M.D. remarks to the U.S. House Committee on Appropriations on the FDA’s Fiscal Year 2019 budget
Read more: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before U.S. House Committee on Appropriations on FDA’s Fiscal Year 2019 budget

US FDA News: FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia

FDA approved Crysvita (burosumab), the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH), a rare form of rickets.
Read more: FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia

Pharma Reviews: Bengaluru highest paying city; pharma, healthcare firms top paymasters

New Delhi: Bengaluru is the highest paying city in the country, while pharma and healthcare is the highest paying industry for talent in India, says a report. According to Randstad Insights, the research and analysis division of Randstad India, the average annual cost to company (CTC) for talent across all ...
Read more: Bengaluru highest paying city; pharma, healthcare firms top paymasters

US FDA News: Statement by Dr. Susan Mayne on FDA efforts to reduce consumer exposure to arsenic in rice

One way FDA oversees food safety is through monitoring of contaminants in food, such as arsenic, assessing potential exposure and taking steps to reduce exposure
Read more: Statement by Dr. Susan Mayne on FDA efforts to reduce consumer exposure to arsenic in rice

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to enhance and modernize the FDA’s approach to medical device safety and innovation

The FDA is releasing the Medical Device Safety Action Plan that outlines our vision for how FDA can continue to enhance our programs and processes to assure the safety of medical devices
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to enhance and modernize the FDA’s approach to medical device safety and innovation

US FDA News: Certain Implantable Cardiac Devices by Abbott (formerly St. Jude Medical): FDA Safety Communication - Battery Performance Alert and Cybersecurity Firmware Updates

If the battery runs out, the ICD or CRT-D will be unable to deliver life-saving pacing or shocks, which could lead to patient death. Posted 04/17/2018
Read more: Certain Implantable Cardiac Devices by Abbott (formerly St. Jude Medical): FDA Safety Communication - Battery Performance Alert and Cybersecurity Firmware Updates

Pharma Reviews: Top-paying jobs, cities in India: Doctors, management professionals, Bangalore lead list

Banglore takes a lead in being the highest paid city in India and pharma and healthcare is the highest paying industry for talent in India, says a report. Employees in Bengaluru earn an average annual CTC (cost to company) of about 10.8 lakhs, says Randstad Insights, the research, and analysis division ...
Read more: Top-paying jobs, cities in India: Doctors, management professionals, Bangalore lead list

Pharma Reviews: Technology funds deliver highest average returns in past one year, pharma funds lag

Among 10 IT technology funds that industry offers, the top 3 funds were Tata Digital India Fund that returned 43.78 percent in the last one year. Aditya Birla Sun Life New Millenium Fund and ICICI Prudential Technology Fund fetched 41.75 percent and 36.50 percent, average returns, respectively.
Read more: Technology funds deliver highest average returns in past one year, pharma funds lag

Pharma Reviews: India's import of China-made medicines has increased 50 per cent in 4 years

It is not only Chinese electronics and engineering goods that have swamped India, but also medicines made in China. And the blow is a double whammy. Not only are medicines made in China making their way into India but they are also hurting Indian pharma companies abroad. The export of ...
Read more: India's import of China-made medicines has increased 50 per cent in 4 years

Pharma Reviews: Bangalore highest paying city; pharma, healthcare firms top paymasters

Bangalore is the highest paying city in the country, while pharma and healthcare is the highest paying industry for talent in India, says a report. According to Randstad Insights, the research and analysis division of Randstad India, the average annual cost to company (CTC) for talent across all levels and ...
Read more: Bangalore highest paying city; pharma, healthcare firms top paymasters

Pharma Reviews: We will continue to engage external consultants, Biocon assures USFDA

According to an executive of a Mumbai-based pharma firm, the USFDA recommends engaging a TPC for resolving specific compliance issues when it feels that the firm's internal team does not have the capability to do the same. Some major TPCs in the Indian pharma sector are Lachman Consultants, ...
Read more: We will continue to engage external consultants, Biocon assures USFDA

Pharma Reviews: Professionals in Bengaluru highest paid; pharma, healthcare companies top paymasters

NEW DELHI: Professionals in Bengaluru are the highest paid with their average annual salaries at Rs 10.8 lakh while pharma and healthcare sector in the country doles out the maximum pay, says a report. The IT capital of India, Bengaluru, pays the highest with an average annual Cost to Company ...
Read more: Professionals in Bengaluru highest paid; pharma, healthcare companies top paymasters

Pharma Jobs: Patient care advisor

Company: Indegene Private Limited
Qualification: B.Pharm, B.Sc, M.Pharm, M.Sc
Experience: 1 to 9
location: Mumbai City
Ref: 22121793
Summary: 1. Counsel patients for improved health related outcomes at home visits, hospital OPD’s and doctor visit through lifestyle management & exercises. 2. Ensure....
Read more: Patient care advisor

Pharma Jobs: Medical Engagement Asssociate

Company: Indegene Private Limited
Experience: 0 to 5
location: Mumbai
Ref: 22121862
Summary: 1. Counsel patients for improved health related outcomes at home visits, hospital OPD’s and doctor visit through lifestyle management & exercises. 2. Ensure execution of PSP in their respective territory as per NP4 approved process....
Read more: Medical Engagement Asssociate

Pharma Reviews: NITI Aayog backs cap on pharma trade margins

The drug industry claims scheduled drugs earn 8% and 16% margin for stockists and retailers, respectively, whereas for non-scheduled drugs, they are 10% and 20%. India's drug price-setting body National Pharmaceutical Pricing Authority (NPPA) uses these margins to fix prices. However, there have ...
Read more: NITI Aayog backs cap on pharma trade margins

Pharma Reviews: Professionals in Bengaluru highest paid; pharma, healthcare cos top paymasters

Professionals in Bengaluru are the highest paid with their average annual salaries at Rs 10.8 lakh while pharma and healthcare sector in the country doles out the maximum pay, says a report. The IT capital of India, Bengaluru, pays the highest with an average annual Cost to Company (CTC) for talent ...
Read more: Professionals in Bengaluru highest paid; pharma, healthcare cos top paymasters

Pharma Reviews: Pharma and Healthcare is the highest paying sector in India: Report

As per Randstad's latest salary trends report, Bangalore is the highest paying city in India and Pharma and Healthcare is the highest paying industry. With an average annual CTC for talent across all levels and functions standing at INR 10.8 lakhs, the IT capital of India, Bangalore, continues to lead the ...
Read more: Pharma and Healthcare is the highest paying sector in India: Report

Pharma Reviews: Bengaluru highest paying city; pharma, healthcare firms top paymasters

Chennai (Rs 800,000), Hyderabad (Rs 790,000) and Kolkata (Rs 720,000) are the other three names on the list of Indian cities paying the highest average salaries for professionals. The report further noted that professionals from the pharma and healthcare industries are paid the highest in India with an ...
Read more: Bengaluru highest paying city; pharma, healthcare firms top paymasters

Pharma Reviews: Bangalore highest paying city; pharma, healthcare firms top paymasters

FMCG, is the third highest paying industry with an average CTC of Rs 9.2 lakh. The IT sector, offering an average annual CTC of Rs 9.1 lakh and infrastructure, real estate and construction at Rs 9.0 lakh take the fourth and fifth position in the list as India's most lucrative industries for professionals.
Read more: Bangalore highest paying city; pharma, healthcare firms top paymasters

Pharma Reviews: Bangalore is India's highest paying city; pharma, healthcare firms top paymasters

NEW DELHI: Bangalore is the highest paying city in the country, while pharma and healthcare is the highest paying industry for talent in India, says a report. According to Randstad Insights, the research and analysis division of Randstad India, the average annual cost to company (CTC) for talent across ...
Read more: Bangalore is India's highest paying city; pharma, healthcare firms top paymasters

Pharma Reviews: $5.6 billion Indian exports may be hit as US weighs tighter policy

For India, the GSP country eligibility review is based on concerns by the US dairy industry and medical device industry alleging Indian trade barriers affecting US exports in those sectors. India has very high import duties on dairy products to protect its domestic industry. It has also recently put price ...
Read more: $5.6 billion Indian exports may be hit as US weighs tighter policy

Pharma Reviews: Preferential Pricing Needed to Boost Medical Devices Market

The Indian Medical Device industry holds immense potential contributing to the growth of healthcare ecosystem. There are number of factors responsible for jeopardising this vertical's growth. Preferential Market Access is need of the hour to buoy domestic industry, says Rajiv Nath, Forum Coordinator, ...
Read more: Preferential Pricing Needed to Boost Medical Devices Market

US FDA News: La FDA toma medidas para proteger a los consumidores de los suplementos alimenticios que contienen niveles peligrosamente altos de cafeína altamente concentrada o pura

: El día de hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) tomó una medida importante para proteger mejor a los consumidores de los peligros de los productos de cafeína altamente concentrada y pura.
Read more: La FDA toma medidas para proteger a los consumidores de los suplementos alimenticios que contienen niveles peligrosamente altos de cafeína altamente concentrada o pura

US FDA News: Coastal Meds to Recall All Products Marketed as Sterile

FDA is alerting health care professionals to a voluntary recall of all non-expired products marketed as sterile made by Coastal Meds due to visible particles in some of the drug vials for injection.
Read more: Coastal Meds to Recall All Products Marketed as Sterile

Pharma Reviews: Tarena helps pharma SMEs to go digital: CEO Suresh Satymurthy

Suresh Satymurthy: Tarnea is a B2B Transaction and Data Analytics company based in Bangalore. We have built, India's first and perhaps the largest cloud based digital platform for pharmaceutical retail - the Tarnea SmartMile™. The company launched its platform Tarnea SmartMile™ in 2014. We have ...
Read more: Tarena helps pharma SMEs to go digital: CEO Suresh Satymurthy

US FDA News: FDA takes step to protect consumers against dietary supplements containing dangerously high levels of extremely concentrated or pure caffeine

Today, the U.S. Food and Drug Administration took an important step to better protect consumers from the dangers of highly concentrated and pure caffeine products.
Read more: FDA takes step to protect consumers against dietary supplements containing dangerously high levels of extremely concentrated or pure caffeine

US FDA News: Acrodose PLus and PL Systems by Haemonetics: Recall - Low pH Readings for Platelets Stored in CLX HP Bag

Platelets with pH lower than 6.2 and a lack of “swirl” may not be viable. Transfusion of these platelets may lead to delayed correction of coagulopathy or low quality prophylactic platelet transfusion.
Read more: Acrodose PLus and PL Systems by Haemonetics: Recall - Low pH Readings for Platelets Stored in CLX HP Bag

US FDA News: Sterile Injectable Products by Premier Pharmacy Labs: Recall - Lack of Sterility Assurance

Administration of non-sterile injection products that are intended to be sterile may result in a site-specific or systemic infection.
Read more: Sterile Injectable Products by Premier Pharmacy Labs: Recall - Lack of Sterility Assurance

US FDA News: FDA finalizes guidances to accelerate the development of reliable, beneficial next generation sequencing-based tests

The FDA today finalized two guidances to drive the efficient development of a novel technology that scans a person’s DNA to diagnose genetic diseases, which are usually hereditary, and guide medical treatments.
Read more: FDA finalizes guidances to accelerate the development of reliable, beneficial next generation sequencing-based tests

Pharma Reviews: Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key

Indian pharmaceutical market (IPM) grew 8.7 percent in March quarter compared to 7.2 percent in the previous quarter indicating recovery. On the flipside –the US business that contributes around 40-50 percent sales of major India drugs makers is expected to remain under pressure without meaningful ...
Read more: Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key

US FDA News: FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems

FDA permits marketing of first medical device to use artificial intelligence to detect greater than a mild level of diabetic retinopathy in the eye of adults who have diabetes.
Read more: FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems

Pharma Reviews: Pharma, IT sectors will face biggest risk from US protectionist moves: Nomura

India's pharmaceutical and IT services companies will face the biggest risk from US protectionist moves, says Nomura. Washington had launched a challenge against Indian export subsidies at the World Trade Organization last month, saying they hurt US companies by letting Indian exporters sell goods ...
Read more: Pharma, IT sectors will face biggest risk from US protectionist moves: Nomura

Pharma Reviews: US To Keep Mounting Pressure On India To Withdraw Price Caps On Medical Devices

In February 2017, the National Pharmaceutical Pricing Authority (NPPA) capped prices of coronary stents to reduce prices by as much as 85%. The price of drug-eluting or drug-coated stents — the most commonly used in India — were cut from around Rs 2 lakh to around Rs 30,000. The NPPA found ...
Read more: US To Keep Mounting Pressure On India To Withdraw Price Caps On Medical Devices

US FDA News: System 83 Plus Automated Endoscope Reprocessors (AERs) by Custom Ultrasonics: FDA Safety Communication - Completed Validation Testing

System 83 Plus AERs may now be used to reprocess only the Olympus TJF-Q180V duodenoscope and the Pentax ED-3490TK duodenoscope.
Read more: System 83 Plus Automated Endoscope Reprocessors (AERs) by Custom Ultrasonics: FDA Safety Communication - Completed Validation Testing

US FDA News: FDA clears first contact lens with light-adaptive technology

FDA clears first contact lens with additive that automatically darkens the lens when exposed to bright light
Read more: FDA clears first contact lens with light-adaptive technology

US FDA News: Maeng Da Red Powder and Capsules by Club 13: Recall - Possible Contamination With Salmonella

Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Read more: Maeng Da Red Powder and Capsules by Club 13: Recall - Possible Contamination With Salmonella

Pharma Reviews: The story of Juneja siblings, the biggest disruptors in Indian pharma space

Mankind has the largest network of medical representatives in India. Sun Pharma's 9,200-strong sales force pales in comparison to Mankind's 12,000-plus. “Theirs is a highly-motivated workforce,” says a senior executive at a global pharma company,on condition of anonymity. “Full credit goes to Rajeev, ...
Read more: The story of Juneja siblings, the biggest disruptors in Indian pharma space

US FDA News: Essure Permanent Birth Control System by Bayer Healthcare: Announcement - FDA Restricts the Sale and Distribution

Sales restricted to only doctors and healthcare facilities who use the FDA-approved “Patient-Doctor Discussion Checklist – Acceptance of Risk and Informed Decision Acknowledgement”.
Read more: Essure Permanent Birth Control System by Bayer Healthcare: Announcement - FDA Restricts the Sale and Distribution

US FDA News: FDA restricts sale and distribution of Essure to protect women and to require that patients receive risk information

FDA is restricting the sale and distribution of the Essure device to only those health care providers who provide information to women about the risks and benefits of this device before they get the permanent contraception implant.
Read more: FDA restricts sale and distribution of Essure to protect women and to require that patients receive risk information

Pharma Reviews: Indian Govt. Plans to Use Blockchain Technology in Curbing the Menace of Fake Drugs

G Shah, secretary general of industry lobby Indian Pharmaceutical Alliance said: “Fake drugs are a concern and if blockchain can help the industry get rid of the problem we are up for it,” He added: “Even simple two-dimensional barcoding, which is not common in India for drugs, comes at a significant ...
Read more: Indian Govt. Plans to Use Blockchain Technology in Curbing the Menace of Fake Drugs

Pharma Reviews: Govt plans leveraging blockchain to weed out the menace of fake drugs

“If the government is willing to consider it that it is an additional cost and compensate it, the industry will have no objection,” said aid D G Shah, secretary general of industry lobby Indian Pharmaceutical Alliance to FactorDaily. Besides leveraging blockchain potential in the pharma industry, the ...
Read more: Govt plans leveraging blockchain to weed out the menace of fake drugs

Pharma Reviews: Pharma firms could report weak numbers

Indian pharmaceutical sector is estimated to account for 3.1 – 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms. It is expected to grow to $100 billion by 2025. The market is expected to grow to $55 billion by 2020, thereby emerging as the sixth largest ...
Read more: Pharma firms could report weak numbers

Pharma Reviews: Interview: James Streeter of Life Sciences Product Strategy for Oracle Health Sciences says ...

The Indian healthcare market is poised to grow from $100 billion in 2016 to $280 billion in 2020, creating huge opportunity for healthcare and healthtech companies. The sector is expected to see adoption of Artificial Intelligence (AI) and Big Data in the entire drug development lifecycle in a big way.
Read more: Interview: James Streeter of Life Sciences Product Strategy for Oracle Health Sciences says ...

Pharma Reviews: Pharma firms could report weak numbers

The troubled pharma sector is expected to report weak Q4FY18 numbers, with their profit after tax (PAT) likely to decline by 9 per cent year-on-year (YoY) ... Indian pharmaceutical sector is estimated to account for 3.1 – 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in ...
Read more: Pharma firms could report weak numbers

Pharma Reviews: Why Indian firms don't innovate

A case in point being how, in 2012, the Indian government stripped pharmaceutical company Bayer of its exclusive rights to sell its cancer treatment drug in India and granted Natco Pharma a licence to sell a generic version of the drug at about 3% of the price Bayer was charging. “It's difficult, to reconcile ...
Read more: Why Indian firms don't innovate

Pharma Reviews: Pharma sector likely to report weak numbers in Q4

The troubled pharma sector is expected to report weak Q4FY18 numbers, with PAT likely to decline by 9 per cent (year-on-year) and appreciation in rupee ... Indian pharmaceutical sector is estimated to account for 3.1 - 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in ...
Read more: Pharma sector likely to report weak numbers in Q4

Pharma Reviews: Pharma sector likely to report weak numbers in Q4

Indian pharmaceutical sector is estimated to account for 3.1 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms. It is expected to grow to USD 100 billion by 2025. The market is expected to grow to USD 55 billion by 2020, thereby emerging as the sixth ...
Read more: Pharma sector likely to report weak numbers in Q4

Pharma Reviews: Dr TV Narayana elected as new president of IPA; J Jayaseelan vice-president of industry division

TV_JJ.jpg Dr. T. V. Narayana, Director of Vikas Institute of Pharmaceutical Sciences in Rajahmundy in Andhra Pradesh has been elected president of Indian Pharmaceutical Association (IPA), the biggest pharmaceutical professional association in the country. Suresh Khanna, Managing Director of ...
Read more: Dr TV Narayana elected as new president of IPA; J Jayaseelan vice-president of industry division

Pharma Reviews: No proposal for a new drug policy at present: Govt

The stakeholders also discussed ways to make India sufficiently self -reliant in end to end indigenous drug manufacturing and ensuring world class quality of ... for research and development to produce innovator drugs and ensuring growth and development to Indian pharma industry,” Mandaviya said.
Read more: No proposal for a new drug policy at present: Govt

Pharma Reviews: The reinvention of Indian drug-makers: They're now selling FMCG products

Latest figures show that the growth rate of India's pharma sector dipped to 5.5 per cent in 2017, the lowest in eight years, due to a range of reasons – drug price controls in the domestic market, a fall in exports to the US due to lapses at US Federal Drug Administration-approved labs, and increasing ...
Read more: The reinvention of Indian drug-makers: They're now selling FMCG products

US FDA News: Kratom-containing Products by Triangle Pharmanaturals: Mandatory Recall - Risk of Salmonella

Salmonella bacteria can cause the foodborne illness salmonellosis. Most people infected with salmonella develop diarrhea, fever and abdominal cramps 12 to 72 hours after infection.
Read more: Kratom-containing Products by Triangle Pharmanaturals: Mandatory Recall - Risk of Salmonella

US FDA News: Dietary Supplements by Nutrizone: Recall - Potential for Salmonella Contamination

Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Read more: Dietary Supplements by Nutrizone: Recall - Potential for Salmonella Contamination

Pharma Reviews: No proposal for a new drug policy at present: Govt

Other issues discussed were "creating an environment for research and development to produce innovator drugs and ensuring growth and development to Indian pharma industry," Mandaviya said. It was a preliminary discussion and no timeline has been fixed in this regard, he added. In reply to a ...
Read more: No proposal for a new drug policy at present: Govt

US FDA News: FDA orders mandatory recall for kratom products due to risk of salmonella

Today, the U.S. Food and Drug Administration announced it has issued a mandatory recall order for all food products containing powdered kratom manufactured, processed, packed, or held by Triangle Pharmanaturals LLC, after several were found to contain salmonella. The agency took this action after the company failed to cooperate with the FDA’s request to conduct a voluntary recall. This is the first time the agency has issued a mandatory recall order to protect Americans from contaminated food products.
Read more: FDA orders mandatory recall for kratom products due to risk of salmonella

Pharma Reviews: Pharma may see recovery with FY19 profit set to jump 20-22%: Crisil

It can be noted that although exports account for only 50 per cent of revenue for the domestic pharma industry, its contribution at the operating profit is higher owing to relatively superior profitability of products sold in regulated markets and that the haemorrhage over the past two years can be pinned ...
Read more: Pharma may see recovery with FY19 profit set to jump 20-22%: Crisil

US FDA News: Pasta De Lassar Andromaco Skin Protectant 25 Percent Zinc Oxide by MarcasUSA: Recall - Potential Contamination

Use of the contaminated product could result in an increased risk of infection.
Read more: Pasta De Lassar Andromaco Skin Protectant 25 Percent Zinc Oxide by MarcasUSA: Recall - Potential Contamination

Pharma Reviews: Pharma revenues from US dipping, says ICRA

Hyderabad: The growth trajectory for Indian pharmaceutical industry is likely to be moderate, in single digit on the back of slowing growth from US given the relatively moderate proportion of large size drugs going off patent, increased competition leading to price erosion in low double digit, generic ...
Read more: Pharma revenues from US dipping, says ICRA

US FDA News: New York raw milk cheese company ordered to stop sales for food safety violations

FDA announces an enforcement action taken against Vulto Creamery of New York. The company cannot sell ready-to-eat raw cheese product until it complies with the consent decree. Vulto was linked to an outbreak last year.
Read more: New York raw milk cheese company ordered to stop sales for food safety violations

Pharma Reviews: ICRA forecasts single digit moderate growth for Indian pharma

ICRA forecasts single digit moderate growth for Indian pharma. Bengaluru, Apr 2 (UNI) The Indian pharma industry is likely to witness a single digit moderate growth on the back of slowing growth from the US given the relatively moderate proportion of large size drugs going off patent. According to a ...
Read more: ICRA forecasts single digit moderate growth for Indian pharma

Pharma Reviews: At the helm at Dr. Reddy's, Erez Israeli will have his task cut out

Interestingly, Israeli is the second top Teva executive to lead a large Indian company. Back in 2012, Sun Pharma had roped in Israel Makov as chairman of the company. Makov had led Teva between 2002 and 2007. Sun had at that time said it expected Makov to help Sun Pharma in globalising its ...
Read more: At the helm at Dr. Reddy's, Erez Israeli will have his task cut out